SOD3 and LAMA4 levels correlate positively with enhanced TIL numbers in a small cohort of stage II CRC patients, and with the T-cell inflammatory signatures in the CRC cohort described in The Cancer Genome Atlas (14). This evidence concerns the gene LAMA4 and colorectal carcinoma.